Related Experiment Video
Updated: Jun 7, 2026
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Glucocerebrosidase mutations in diffuse Lewy body disease
Kenya Nishioka1, Owen A Ross, Carles Vilariño-Güell
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Parkinsonism & Related Disorders
|October 26, 2010
Summary
Glucocerebrosidase gene (GBA) mutations are linked to Parkinson's disease. This study found GBA mutations in diffuse Lewy body disease, suggesting a link to wider brain involvement compared to typical Parkinson's disease.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Mutations in the glucocerebrosidase gene (GBA) are recognized risk factors for Parkinson's disease and Lewy body disorders.
- Previous research indicates a genetic predisposition to these neurodegenerative conditions.
Purpose of the Study:
- To investigate the prevalence of GBA mutations in pathologically confirmed diffuse Lewy body disease.
- To explore the relationship between GBA mutations and the pattern of Lewy body distribution in the brain.
Main Methods:
- Pathological diagnosis of diffuse Lewy body disease in 59 cases.
- Genetic analysis to identify mutations in the glucocerebrosidase gene (GBA).
Main Results:
- GBA mutations were identified in 6.8% (4/59) of the studied cases.
- The presence of GBA mutations correlated with a diffuse Lewy body distribution pattern, particularly involving the cerebral cortex.
Conclusions:
- GBA mutations are associated with diffuse Lewy body disease.
- This suggests GBA mutations may influence the extent and location of Lewy body pathology, differing from typical Parkinson's disease patterns.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...